{"nct_id":"NCT00759239","title":"Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension","status":"COMPLETED","status_verified_date":"2012-01","start_date":"2008-09","start_date_type":null,"primary_completion_date":"2011-01","primary_completion_date_type":"ACTUAL","completion_date":"2011-01","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["ALC"]}